Mallinckrodt has expanded its agreement with group purchasing organization Premier, adding new products and extending their existing contract by two years. New Mallinckrodt technologies and products added to the partnership include Nellcor pulse
Mallinckrodt has expanded its agreement with group purchasing organization Premier, adding new products and extending their existing contract by two years. New Mallinckrodt technologies and products added to the partnership include Nellcor pulse oximeters and sensors, Liebel-Flarsheim power injector disposables, and the Optison ultrasound contrast agent (developed by San Diego-based Molecular Biosystems).
The earlier agreement between Premier and Mallinckrodt covered other Mallinckrodt contrast imaging agents, radiopharmaceuticals and related products, endotracheal tubes, tracheostomy tubes, and temperature monitoring systems. All of those items will remain under the new expanded agreement, which will conclude at the end of 2006, according to St. Louis-based Mallinckrodt.
Can MRI-Based AI Enhance Pre-Op Prediction of Tumor Deposits in Patients with Rectal Cancer?
October 31st 2024For patients with rectal cancer, an emerging nomogram that combines deep learning and clinical factors had greater than 16 percent and 23 percent increases in accuracy and specificity, respectively, for pre-op prediction of tumor deposits in comparison to clinical factors alone.
Artifact Reduction Drives Technology Advances with Updated Version of Echelon Synergy MRI System
October 30th 2024Emerging technologies included with the 10th version of the 1.5T MRI platform include Synergy DLR Clear and Synergy Vision that are geared toward mitigating common challenges with artifacts.